Categories: News

Financière de Tubize – Annual report 2023

FINANCIERE DE TUBIZE SA/NV

Allée de la Recherche 60, 1070 Brussels

Contact: investorrelations@financiere-tubize.be

Annual Report 2023

Regulated information
16 March 2024

The board of directors of Financière de Tubize has established the 2023 annual report. This report is available on the website www.financiere-tubize.be

  • Profit for the financial year: € 88.2 million (€ 85.2 million in 2022, +3,5%),
  • Increase of outstanding bank borrowings from € 47.8 million at 31 December 2022 to € 79.2 million at 31 December 2023,
  • Acquisition of 1,043,881 UCB shares, increasing the holding of the Company in UCB from 35.70% on 31 December 2022 to 36.24% on 31 December 2023.

If the general shareholders meeting of 26 April 2024 approves the 2023 annual accounts, including the proposed result appropriation, a gross dividend of € 0.97 (compared to €0.86 for financial year 2022, an increase of 12.8%) will be payable as from 3rd of May 2024 onwards at the offices, seats and branches of BNP Paribas Fortis, in exchange of coupon n° 19.

Ex-dividend          30 April 2024
Record date          2 May 2024
Payment date       3 May 2024

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

8 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

8 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

1 day ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

1 day ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

1 day ago

Oxford Healthspan to Introduce New Primeadine® GF Powder Through a ‘Longevity Shot’ Experience During Grammy Week in Los Angeles

Science-Backed Spermidine Ritual Brings Cellular Renewal to a High-Performance Cultural Moment Primeadine Longevity Shot Primeadine…

1 day ago